Slip Opinion
D.N.J.May 11, 2023Background
- The Court issued Case Management Order No. 60 requiring plaintiffs in identified PPI MDL cases to either (1) file proof of service on Pfizer under Fed. R. Civ. P. 4(m), (2) voluntarily dismiss Pfizer, or (3) show cause why Pfizer should not be dismissed.
- Deadlines for responses and oppositions were extended multiple times; CMO No. 60 itself did not extend the Rule 4(m) service period—it required plaintiffs to demonstrate that service already was timely or show cause.
- Exhibit A lists 640 plaintiffs who failed to comply: 61 never served Pfizer; in 579 cases service (where claimed) occurred after CMO No. 60—often years after the 90‑day Rule 4(m) window (many >3 years late).
- Plaintiffs largely submitted near-identical, unsupported responses focusing on waiver and tolling rather than explaining efforts to effect timely service or why delays occurred.
- The Court found plaintiffs failed to show good cause for late or non‑service, that Pfizer was prejudiced by the delays, and that discretionary relief was not warranted; the Court dismissed Pfizer without prejudice from the cases in Exhibit A.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether plaintiffs showed "good cause" under Rule 4(m) for failure to timely serve Pfizer | Plaintiffs generally argued tolling and other MDL procedures justified delay and urged the Court to allow extension | Pfizer argued plaintiffs did not make any showing of good faith or reasonable efforts to serve and that many services were years late or never done | Plaintiffs failed to show good cause; factor analysis (efforts, prejudice, motion for enlargement) favors dismissal |
| Whether the Court should exercise its discretion to extend service time absent good cause | Plaintiffs asked the Court to exercise discretion, citing tolling and alleged notice | Pfizer argued lack of actual notice, prejudice, expired statutes of limitations, and counsel representation weigh against extension | Court declined discretionary extension after weighing notice, prejudice, SOL concerns, defendant conduct, and counsel involvement |
| Whether Pfizer waived defense of insufficient/untimely service by prior filings or conduct | Plaintiffs asserted waiver based on Pfizer filings (answers, notices of appearance, motions) or general participation in MDL | Pfizer showed CMO limits on defense-raising; it did not file or abandon Rule 12(b)(5) defenses in these cases and did not meaningfully participate in individual dockets | Court held Pfizer did not waive the defense of insufficient service in the Exhibit A cases |
| Whether tolling agreement or membership on tolling spreadsheet gave Pfizer "actual notice" of specific suits | Plaintiffs argued tolling and shared claimant data put Pfizer on notice of claims | Pfizer and the Court noted the tolling data did not identify which defendant or product corresponded to a claimant and thus did not constitute actual legal notice | Tolling did not equate to actual notice sufficient to excuse Rule 4(m) noncompliance |
Key Cases Cited
- MCI Telecomms. Corp. v. Teleconcepts, Inc., 71 F.3d 1086 (3d Cir. 1995) (establishes good‑cause standard for Rule 4(m) extensions and factors to consider)
- Petrucelli v. Bohringer & Ratzinger, 46 F.3d 1298 (3d Cir. 1995) (court has discretion to dismiss or extend service period absent good cause; counsel’s inadvertence not necessarily excusing delay)
- McCurdy v. American Board of Plastic Surgery, 157 F.3d 191 (3d Cir. 1998) (burden on plaintiff to demonstrate good cause or persuade court to exercise discretion)
- Chiang v. U.S. Small Business Admin., [citation="331 Fed. App'x 113"] (3d Cir. 2009) (factors guiding discretionary extensions under Rule 4(m))
- King v. Taylor, 694 F.3d 650 (6th Cir. 2012) (defendant’s extensive active litigation participation may support finding of waiver for service defense)
- Edwards v. Hillman, [citation="849 F. App'x 23"] (3d Cir. 2021) (discusses reliance on Petrucelli regarding court discretion when no good cause shown)